OHE at ISPOR Europe: Presentations

The OHE gave the following presentations at ISPOR 17th Annual European Congress in Amsterdam, The Netherlands.

What Value Do We Place on a Cure? Value Demonstration Challenges Associated with Innovator and Regenerative Therapies in the EU, North America, and Asia.

Moderator: Eric C Faulkner (University of North Carolina, Chapel Hill) Panelists: Adrian Towse (OHE), Don Husereau, University of Ottawa and UMIT, Joshua J. Carlson (VeriTech Corporation).

Regenerative medicine akt_nov14 from Office of Health Economics

An Introduction to Multi-criteria Decision Analysis in Health Care Decision Making – Emerging Good Practices.

Chair: Maarten J IJzerman, University of Twente and MIRA Institute for Biomedical Technology & Technical Medicine.; Speakers: Nancy Devlin (OHE), Praveen Thokala (University of Sheffield) and Kevin Marsh (Evida).

MCDA devlin nov14 from Office of Health Economics

Earlier Access to Innovation – Is It worth It?

Moderator: Adrian Towse (OHE), with.Hans-Georg Eichler (EMA), Richard Bergstrom (EFPIA), Carole Longson (NICE), and Alric Reuther (IQWiG).

Adaptive pathways intro_ispor_second_plenary_nov14 from Office of Health Economics

Value-based Assessment for NICE: How to Do the Calculations.

Discussion Leaders: Jeanette Kusel (Costello Medical Consulting Ltd), Meindert Boysen (NICE), Koonal K. Shah (OHE) and Anthony J Hatswell (BresMed).

Ispor workshop value-based_assess_nice_kks_nov2014 from Office of Health Economics

News & Insights

Latest Research & Publications

An Analysis of NICE’s Optimised Decisions from 2015 to 2024

Analysing Global Immunisation Expenditure

The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region

Challenges and Solutions for Budget Impact Analysis of Gene Therapies

Establishing the Economic Value of Carbon-Minimal Inhalers

The Importance of Diversity of Supply in Rare Diseases Markets

2023 OHE Annual Report to the Charity Commission

Employer Costs from Respiratory Infections

All Publications

OHE at ISPOR Europe: Presentations

Related News

Assessing the Productivity Value of Vaccines in Health Technology Assessment: Worth a Shot?

Are Discount Rates Used in UK Vaccine Economic Evaluations Jeopardising Investment in Immunisation Programmes?

NICE ‘Optimised’ Recommendations: What Do They Mean for Patient Access?

How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.

Share on Mastodon